{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T03:07:35Z","timestamp":1786763255177,"version":"build-2736575974"},"reference-count":171,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T00:00:00Z","timestamp":1685404800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005869","name":"Universit\u00e9 de Fribourg","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005869","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.euroneuro.2023.05.008","type":"journal-article","created":{"date-parts":[[2023,6,21]],"date-time":"2023-06-21T07:25:56Z","timestamp":1687332356000},"page":"1-14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"special_numbering":"C","title":["Psychedelics in the treatment of eating disorders: Rationale and potential mechanisms"],"prefix":"10.1016","volume":"75","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9528-404X","authenticated-orcid":false,"given":"Abigail","family":"Calder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3055-818X","authenticated-orcid":false,"given":"Seline","family":"Mock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Friedli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8436-6549","authenticated-orcid":false,"given":"Patrick","family":"Pasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8311-0138","authenticated-orcid":false,"given":"Gregor","family":"Hasler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2023.05.008_bib0124","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2020.100538","article-title":"Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: an open-label safety and feasibility pilot study","volume":"27","author":"Anderson","year":"2020","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.euroneuro.2023.05.008_bib0050","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.neubiorev.2013.01.029","article-title":"The free-energy self: a predictive coding account of self-recognition","volume":"41","author":"Apps","year":"2014","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"7","key":"10.1016\/j.euroneuro.2023.05.008_bib0003","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1001\/archgenpsychiatry.2011.74","article-title":"Mortality rates in patients with anorexia nervosa and other eating disorders","volume":"68","author":"Arcelus","year":"2011","journal-title":"Arch. Gen. Psychiatry"},{"issue":"7","key":"10.1016\/j.euroneuro.2023.05.008_bib0125","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1001\/archgenpsychiatry.2011.74","article-title":"Mortality rates in patients with anorexia nervosa and other eating disorders. A meta-analysis of 36 studies","volume":"68","author":"Arcelus","year":"2011","journal-title":"Arch. Gen. Psychiatry"},{"issue":"6","key":"10.1016\/j.euroneuro.2023.05.008_bib0012","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1176\/appi.ajp.2018.18101125","article-title":"Olanzapine versus placebo in adult outpatients with anorexia nervosa: a randomized clinical trial","volume":"176","author":"Attia","year":"2019","journal-title":"Am. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.euroneuro.2023.05.008_bib0140","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.neuropharm.2011.11.010","article-title":"Dysregulation of brain reward systems in eating disorders: neurochemical information from animal models of binge eating, bulimia nervosa, and anorexia nervosa","volume":"63","author":"Avena","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.euroneuro.2023.05.008_bib0108","doi-asserted-by":"crossref","DOI":"10.3402\/ejpt.v4i0.22482","article-title":"The prevalence and impact of trauma history in eating disorder patients","volume":"4","author":"Backholm","year":"2013","journal-title":"Eur. J. Psychotraumatol"},{"issue":"1","key":"10.1016\/j.euroneuro.2023.05.008_bib0091","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1038\/s41598-020-59282-y","article-title":"Emotions and brain function are altered up to one month after a single high dose of psilocybin","volume":"10","author":"Barrett","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.euroneuro.2023.05.008_bib0164","article-title":"Acute effects of psilocybin after escitalopram or placebo pretreatment in a randomized, double-blind, placebo-controlled, crossover study in healthy subjects","author":"Becker","year":"2021","journal-title":"Clin. Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.euroneuro.2023.05.008_bib0115","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00213-009-1635-z","article-title":"Effects of MDMA on sociability and neural response to social threat and social reward","volume":"207","author":"Bedi","year":"2009","journal-title":"Psychopharmacology (Berl.)"},{"issue":"2","key":"10.1016\/j.euroneuro.2023.05.008_bib0163","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/00131746-200503000-00002","article-title":"The therapeutic alliance in the treatment of personality disorders","volume":"11","author":"Bender","year":"2005","journal-title":"J. Psychiatr. Pract."},{"issue":"3","key":"10.1016\/j.euroneuro.2023.05.008_bib0098","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1177\/0269881114565144","article-title":"Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study","volume":"29","author":"Bogenschutz","year":"2015","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2023.05.008_bib0097","doi-asserted-by":"crossref","first-page":"100","DOI":"10.3389\/fphar.2018.00100","article-title":"Clinical interpretations of patient experience in a trial of psilocybin-assisted psychotherapy for alcohol use disorder","volume":"9","author":"Bogenschutz","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.euroneuro.2023.05.008_bib0099","doi-asserted-by":"crossref","DOI":"10.1001\/jamapsychiatry.2022.2096","article-title":"Percentage of heavy drinking days following psilocybin-assisted psychotherapy vs placebo in the treatment of adult patients with alcohol use disorder: a randomized clinical trial","author":"Bogenschutz","year":"2022","journal-title":"JAMA Psychiatry"},{"issue":"7","key":"10.1016\/j.euroneuro.2023.05.008_bib0064","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/eat.20869","article-title":"Reward abnormalities among women with full and subthreshold bulimia nervosa: a functional magnetic resonance imaging study","volume":"44","author":"Bohon","year":"2011","journal-title":"Int. J. Eat. Disord."},{"issue":"3","key":"10.1016\/j.euroneuro.2023.05.008_bib0027","doi-asserted-by":"crossref","first-page":"E218","DOI":"10.1503\/jpn.220090","article-title":"Serotonergic psychedelic treatment for obesity and eating disorders: potential expectations and caveats for emerging studies","volume":"47","author":"Borgland","year":"2022","journal-title":"J. Psychiatry Neurosci."},{"issue":"1","key":"10.1016\/j.euroneuro.2023.05.008_bib0162","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s40345-022-00265-5","article-title":"Psychedelics in the treatment of unipolar and bipolar depression","volume":"10","author":"Bosch","year":"2022","journal-title":"Int. J. Bipolar Disord."},{"issue":"9","key":"10.1016\/j.euroneuro.2023.05.008_bib0018","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s40263-020-00748-y","article-title":"Psychedelic treatments for psychiatric disorders: a systematic review and thematic synthesis of patient experiences in qualitative studies","volume":"34","author":"Breeksema","year":"2020","journal-title":"CNS Drugs"},{"key":"10.1016\/j.euroneuro.2023.05.008_bib0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.mehy.2020.110367","article-title":"The potential use of N-methyl-3,4-methylenedioxyamphetamine (MDMA) assisted psychotherapy in the treatment of eating disorders comorbid with PTSD","volume":"146","author":"Brewerton","year":"2021","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.euroneuro.2023.05.008_bib0038","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jpsychires.2022.03.008","article-title":"MDMA-assisted therapy significantly reduces eating disorder symptoms in a randomized placebo-controlled trial of adults with severe PTSD","volume":"149","author":"Brewerton","year":"2022","journal-title":"J. Psychiatr. Res."},{"issue":"4","key":"10.1016\/j.euroneuro.2023.05.008_bib0004","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1080\/10640260701454311","article-title":"Eating disorders, trauma, and comorbidity: focus on PTSD","volume":"15","author":"Brewerton","year":"2007","journal-title":"Eat Disord."},{"issue":"4","key":"10.1016\/j.euroneuro.2023.05.008_bib0006","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1080\/10926771.2018.1532940","article-title":"An overview of trauma-informed care and practice for eating disorders","volume":"28","author":"Brewerton","year":"2018","journal-title":"J. Aggress. Maltreat. Trauma"},{"issue":"4","key":"10.1016\/j.euroneuro.2023.05.008_bib0101","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1080\/10926771.2018.1532940","article-title":"An Overview of Trauma-Informed Care and Practice for Eating Disorders","volume":"28","author":"Brewerton","year":"2019","journal-title":"J. Aggress. Maltreat. Trauma"},{"key":"10.1016\/j.euroneuro.2023.05.008_bib0167","doi-asserted-by":"crossref","first-page":"g1626","DOI":"10.1136\/bmj.g1626","article-title":"Serotonin syndrome","volume":"348","author":"Buckley","year":"2014","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.euroneuro.2023.05.008_bib0056","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/s41593-022-01071-z","article-title":"Genetics and neurobiology of eating disorders","volume":"25","author":"Bulik","year":"2022","journal-title":"Nat. Neurosci."},{"issue":"2","key":"10.1016\/j.euroneuro.2023.05.008_bib0136","doi-asserted-by":"crossref","DOI":"10.3390\/nu13020500","article-title":"The Role of the Gut Microbiome, Immunity, and Neuroinflammation in the Pathophysiology of Eating Disorders","volume":"13","author":"Butler","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.euroneuro.2023.05.008_bib0090","article-title":"Towards an understanding of psychedelic-induced neuroplasticity","author":"Calder","year":"2022","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.euroneuro.2023.05.008_bib0048","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1124\/pr.118.017160","article-title":"REBUS and the anarchic brain: toward a unified model of the brain action of psychedelics","volume":"71","author":"Carhart-Harris","year":"2019","journal-title":"Pharmacol. Rev."},{"issue":"7","key":"10.1016\/j.euroneuro.2023.05.008_bib0078","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S2215-0366(16)30065-7","article-title":"Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study","volume":"3","author":"Carhart-Harris","year":"2016","journal-title":"Lancet Psychiatry"},{"issue":"15","key":"10.1016\/j.euroneuro.2023.05.008_bib0129","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1056\/NEJMoa2032994","article-title":"Trial of Psilocybin versus Escitalopram for Depression","volume":"384","author":"Carhart-Harris","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.euroneuro.2023.05.008_bib0138","series-title":"Poster presented at: Annual Meeting of the American College of Neuropsychopharmacology; December 2022","article-title":"Psilocybin alters behavior and intestinal microbiota in a wild type mouse model by mechanisms that are not fully dependent on 5-HT2A and 5-HT2C receptors","author":"Cordner","year":"2022"},{"key":"10.1016\/j.euroneuro.2023.05.008_bib0054","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nrn2555","article-title":"How do you feel \u2014 Now? The anterior insula and human awareness","volume":"10","author":"Craig","year":"2009","journal-title":"Nat. Rev. Neurosci."},{"issue":"10","key":"10.1016\/j.euroneuro.2023.05.008_bib0055","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1038\/79871","article-title":"Subcortical and cortical brain activity during the feeling of self-generated emotions","volume":"3","author":"Damasio","year":"2000","journal-title":"Nat. Neurosci."},{"issue":"3","key":"10.1016\/j.euroneuro.2023.05.008_bib0104","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/(SICI)1098-108X(199704)21:3<213::AID-EAT2>3.0.CO;2-N","article-title":"The National Women's Study: relationship of victimization and posttraumatic stress disorder to bulimia nervosa","volume":"21","author":"Dansky","year":"1997","journal-title":"Int. J. Eat. Disord."},{"key":"10.1016\/j.euroneuro.2023.05.008_bib0046","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s40337-015-0060-4","article-title":"Dysfunctional metacognition and drive for thinness in typical and atypical anorexia nervosa","volume":"3","author":"Davenport","year":"2015","journal-title":"J Eat Disord"},{"issue":"6","key":"10.1016\/j.euroneuro.2023.05.008_bib0009","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1097\/YCO.0000000000000358","article-title":"Pharmacotherapy of eating disorders","volume":"30","author":"Davis","year":"2017","journal-title":"Curr. Opin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2023.05.008_bib0010","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.19847.1","article-title":"Recent advances in therapies for eating disorders","volume":"8","author":"Davis","year":"2019","journal-title":"F1000Res."},{"issue":"5","key":"10.1016\/j.euroneuro.2023.05.008_bib0132","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1001\/jamapsychiatry.2020.3285","article-title":"Effects of psilocybin-assisted therapy on major depressive disorder: a randomized clinical trial","volume":"78","author":"Davis","year":"2021","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"10.1016\/j.euroneuro.2023.05.008_bib0016","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s40337-014-0027-x","article-title":"Meta analysis on the efficacy of pharmacotherapy versus placebo on anorexia nervosa","volume":"2","author":"de Vos","year":"2014","journal-title":"J. Eat Disord."},{"issue":"03","key":"10.1016\/j.euroneuro.2023.05.008_bib0028","doi-asserted-by":"crossref","DOI":"10.26502\/fjwhd.2644-28840044","article-title":"Ketamine in a Patient with Comorbid Anorexia and MDD","volume":"03","author":"Dechant","year":"2020","journal-title":"J. Women's Health Develop."},{"key":"10.1016\/j.euroneuro.2023.05.008_bib0001","series-title":"Diagnostic and Statistical Manual of Mental Disorders: DSM-5\u2122","year":"2013"},{"issue":"11","key":"10.1016\/j.euroneuro.2023.05.008_bib0119","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1038\/npp.2016.82","article-title":"LSD acutely impairs fear recognition and enhances emotional empathy and sociality","volume":"41","author":"Dolder","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2023.05.008_bib0021","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.2147\/JPR.S360733","article-title":"Ketamine assisted psychotherapy: a systematic narrative review of the literature","volume":"15","author":"Drozdz","year":"2022","journal-title":"J. Pain Res."},{"issue":"1","key":"10.1016\/j.euroneuro.2023.05.008_bib0109","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/jts.21664","article-title":"Early adult sexual assault and disordered eating: the mediating role of posttraumatic stress symptoms","volume":"25","author":"Dubosc","year":"2012","journal-title":"J. Trauma Stress"},{"issue":"7","key":"10.1016\/j.euroneuro.2023.05.008_bib0068","article-title":"Abnormal social reward responses in anorexia nervosa: an fMRI study","volume":"10","author":"El-Deredy","year":"2015","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.euroneuro.2023.05.008_bib0168","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1192\/apt.bp.114.013037","article-title":"Serotonin syndrome: a spectrum of toxicity","volume":"21","author":"Ellahi","year":"2018","journal-title":"BJPsych. Adv."},{"issue":"2","key":"10.1016\/j.euroneuro.2023.05.008_bib0123","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1176\/appi.ajp.2020.20050596","article-title":"A randomized controlled trial of repeated ketamine administration for chronic posttraumatic stress disorder","volume":"178","author":"Feder","year":"2021","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2023.05.008_bib0065","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3389\/fnins.2020.00043","article-title":"Rethinking therapeutic strategies for anorexia nervosa: insights from psychedelic medicine and animal models","volume":"14","author":"Foldi","year":"2020","journal-title":"Front. Neurosci."},{"issue":"10","key":"10.1016\/j.euroneuro.2023.05.008_bib0075","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1001\/jamapsychiatry.2018.2151","article-title":"Association of brain reward learning response with harm avoidance, weight gain, and hypothalamic effective connectivity in adolescent anorexia nervosa","volume":"75","author":"Frank","year":"2018","journal-title":"JAMA Psychiatry"},{"issue":"4","key":"10.1016\/j.euroneuro.2023.05.008_bib0057","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.chc.2019.05.007","article-title":"The neurobiology of eating disorders","volume":"28","author":"Frank","year":"2019","journal-title":"Child Adolesc. Psychiatr. Clin. N. Am."},{"key":"10.1016\/j.euroneuro.2023.05.008_bib0093","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s40337-016-0104-4","article-title":"Dimensions of control and their relation to disordered eating behaviours and obsessive-compulsive symptoms","volume":"4","author":"Froreich","year":"2016","journal-title":"J. Eat Disord."},{"issue":"4","key":"10.1016\/j.euroneuro.2023.05.008_bib0116","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S0893-133X(00)00130-5","article-title":"Vollenweider FX. 3,4-Methylenedioxymethamphetamine (MDMA) modulates cortical and limbic brain activity as measured by [H215 O]-PET in healthy humans","volume":"23","author":"Gamma","year":"2000","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"10.1016\/j.euroneuro.2023.05.008_bib0024","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1080\/09540261.2018.1486289","article-title":"Current perspectives on psychedelic therapy: use of serotonergic hallucinogens in clinical interventions","volume":"30","author":"Garcia-Romeu","year":"2018","journal-title":"Int. Rev. Psychiatry"},{"issue":"7","key":"10.1016\/j.euroneuro.2023.05.008_bib0127","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/NMD.0000000000000113","article-title":"Safety and efficacy of lysergic acid diethylamide-assisted psychotherapy for anxiety associated with life-threatening diseases","volume":"202","author":"Gasser","year":"2014","journal-title":"J. Nerv. Ment. Dis."},{"issue":"1","key":"10.1016\/j.euroneuro.2023.05.008_bib0150","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1177\/0269881114555249","article-title":"LSD-assisted psychotherapy for anxiety associated with a life-threatening disease: a qualitative study of acute and sustained subjective effects","volume":"29","author":"Gasser","year":"2015","journal-title":"J. Psychopharmacol."},{"issue":"11\u201312","key":"10.1016\/j.euroneuro.2023.05.008_bib0052","first-page":"131","article-title":"Expanding the scientific study of self-experience with psychedelics","volume":"25","author":"Girn","year":"2018","journal-title":"J. Conscious. Stud."},{"key":"10.1016\/j.euroneuro.2023.05.008_bib0079","article-title":"Low doses of lysergic acid diethylamide (LSD) increase reward-related brain activity","author":"Glazer","year":"2022","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.euroneuro.2023.05.008_bib0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10503309712331331843","article-title":"Research-informed psychotherapy","volume":"7","author":"Grawe","year":"1997","journal-title":"Psychotherapy Res."},{"issue":"12","key":"10.1016\/j.euroneuro.2023.05.008_bib0130","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1177\/0269881116675513","article-title":"Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: a randomized double-blind trial","volume":"30","author":"Griffiths","year":"2016","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2023.05.008_bib0026","doi-asserted-by":"crossref","DOI":"10.1007\/s11920-022-01394-5","article-title":"Psychedelic-assisted therapy for people with eating disorders","author":"Gukasyan","year":"2022","journal-title":"Curr. Psychiatry Rep."},{"issue":"1","key":"10.1016\/j.euroneuro.2023.05.008_bib0126","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s40337-022-00654-2","article-title":"Psychiatric and medical comorbidities of eating disorders: findings from a rapid review of the literature","volume":"10","author":"Hambleton","year":"2022","journal-title":"J. Eat Disord."},{"key":"10.1016\/j.euroneuro.2023.05.008_bib0113","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.euroneuro.2022.02.006","article-title":"Toward the \"helioscope\" hypothesis of psychedelic therapy","volume":"57","author":"Hasler","year":"2022","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"1","key":"10.1016\/j.euroneuro.2023.05.008_bib0013","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/imj.14691","article-title":"Current approach to eating disorders: a clinical update","volume":"50","author":"Hay","year":"2020","journal-title":"Intern. Med. J."},{"issue":"5","key":"10.1016\/j.euroneuro.2023.05.008_bib0066","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1093\/cercor\/bhaa369","article-title":"Resting state hypoconnectivity of reward networks in binge eating disorder","volume":"31","author":"Haynos","year":"2021","journal-title":"Cereb. Cortex"},{"issue":"17","key":"10.1016\/j.euroneuro.2023.05.008_bib0077","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2022489118","article-title":"Harnessing psilocybin: antidepressant-like behavioral and synaptic actions of psilocybin are independent of 5-HT2R activation in mice","volume":"118","author":"Hesselgrave","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.euroneuro.2023.05.008_bib0049","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.neubiorev.2019.12.006","article-title":"Neuropharmacological modulation of the aberrant bodily self through psychedelics","volume":"108","author":"Ho","year":"2020","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"3","key":"10.1016\/j.euroneuro.2023.05.008_bib0082","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/s41386-019-0569-3","article-title":"Distinct acute effects of LSD, MDMA, and d-amphetamine in healthy subjects","volume":"45","author":"Holze","year":"2019","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2023.05.008_bib0083","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.711255","article-title":"Role of the 5-HT2A receptor in acute effects of LSD on empathy and circulating oxytocin","volume":"12","author":"Holze","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.euroneuro.2023.05.008_bib0170","article-title":"Safety pharmacology of acute LSD administration in healthy subjects","author":"Holze","year":"2021","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.euroneuro.2023.05.008_bib0085","doi-asserted-by":"crossref","DOI":"10.1038\/s41386-022-01297-2","article-title":"Direct comparison of the acute effects of lysergic acid diethylamide and psilocybin in a double-blind placebo-controlled study in healthy subjects","author":"Holze","year":"2022","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2023.05.008_bib0128","article-title":"Lysergic acid diethylamide-assisted therapy in patients with anxiety with and without a life-threatening illness A randomized, double-blind, placebo-controlled Phase II study","author":"Holze","year":"2022","journal-title":"Biol. Psychiatry"},{"issue":"5","key":"10.1016\/j.euroneuro.2023.05.008_bib0107","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.chiabu.2007.07.011","article-title":"Mediational significance of PTSD in the relationship of sexual trauma and eating disorders","volume":"32","author":"Holzer","year":"2008","journal-title":"Child Abuse Negl."},{"issue":"6","key":"10.1016\/j.euroneuro.2023.05.008_bib0156","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1177\/0269881108093587","article-title":"Human hallucinogen research: guidelines for safety","volume":"22","author":"Johnson","year":"2008","journal-title":"J. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.euroneuro.2023.05.008_bib0141","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3109\/00952990.2016.1170135","article-title":"Long-term follow-up of psilocybin-facilitated smoking cessation","volume":"43","author":"Johnson","year":"2017","journal-title":"Am. J. Drug Alcohol Abuse"},{"key":"10.1016\/j.euroneuro.2023.05.008_bib0159","article-title":"The safety and efficacy of psychedelic-assisted therapies for older adults: knowns and unknowns","author":"Johnston","year":"2022","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.euroneuro.2023.05.008_bib0080","first-page":"1","article-title":"Effect of lysergic acid diethylamide (LSD) on reinforcement learning in humans","author":"Kanen","year":"2022","journal-title":"Psychol. Med."},{"issue":"1","key":"10.1016\/j.euroneuro.2023.05.008_bib0007","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.physbeh.2007.11.037","article-title":"Neurobiology of anorexia and bulimia nervosa","volume":"94","author":"Kaye","year":"2008","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.euroneuro.2023.05.008_bib0045","series-title":"The Wiley Handbook of Eating Disorders","first-page":"285","article-title":"Body image disturbance and the development of eating disorders","author":"Kearney-Cooke","year":"2015"},{"key":"10.1016\/j.euroneuro.2023.05.008_bib0047","series-title":"The Wiley Handbook of Eating Disorders","first-page":"283","article-title":"Body image disturbance and the development of eating disorders","author":"Kearney-Cooke","year":"2015"},{"issue":"5","key":"10.1016\/j.euroneuro.2023.05.008_bib0067","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.neuropsychologia.2012.01.036","article-title":"Reward processing in anorexia nervosa","volume":"50","author":"Keating","year":"2012","journal-title":"Neuropsychologia"},{"issue":"3","key":"10.1016\/j.euroneuro.2023.05.008_bib0017","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/eat.20810","article-title":"Update on course and outcome in eating disorders","volume":"43","author":"Keel","year":"2010","journal-title":"Int. J. Eat. Disord."},{"issue":"10","key":"10.1016\/j.euroneuro.2023.05.008_bib0053","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0163921","article-title":"A virtual reality full body illusion improves body image disturbance in anorexia nervosa","volume":"11","author":"Keizer","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.euroneuro.2023.05.008_bib0008","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.neubiorev.2016.01.013","article-title":"The neurobiological basis of binge-eating disorder","volume":"63","author":"Kessler","year":"2016","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"9","key":"10.1016\/j.euroneuro.2023.05.008_bib0139","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1097\/PSY.0000000000000247","article-title":"The intestinal microbiota in acute anorexia nervosa and during renourishment: relationship to depression, anxiety, and eating disorder psychopathology","volume":"77","author":"Kleiman","year":"2015","journal-title":"Psychosom. Med."},{"issue":"9","key":"10.1016\/j.euroneuro.2023.05.008_bib0039","doi-asserted-by":"crossref","first-page":"S270","DOI":"10.1016\/j.biopsych.2022.02.686","article-title":"P450. Pilot study evaluation of psilocybin therapy for anorexia nervosa: safety, acceptability, and preliminary efficacy","volume":"91","author":"Knatz Peck","year":"2022","journal-title":"Biol. Psychiatry"},{"issue":"9","key":"10.1016\/j.euroneuro.2023.05.008_bib0041","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopsych.2022.02.686","article-title":"P450. Pilot study evaluation of psilocybin therapy for anorexia nervosa: safety, acceptability, and preliminary efficacy","volume":"91","author":"Knatz Peck","year":"2022","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2023.05.008_bib0025","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.661233","article-title":"Does psychedelic therapy have a transdiagnostic action and prophylactic potential?","volume":"12","author":"Ko\u010d\u00e1rov\u00e1","year":"2021","journal-title":"Front. Psychiatry"},{"issue":"8","key":"10.1016\/j.euroneuro.2023.05.008_bib0071","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1002\/eat.23526","article-title":"Disorder specific rewarding stimuli in anorexia nervosa","volume":"54","author":"Kogel","year":"2021","journal-title":"Int. J. Eat. Disord."},{"issue":"8","key":"10.1016\/j.euroneuro.2023.05.008_bib0118","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.biopsych.2014.04.010","article-title":"Psilocybin-induced decrease in amygdala reactivity correlates with enhanced positive mood in healthy volunteers","volume":"78","author":"Kraehenmann","year":"2015","journal-title":"Biol. Psychiatry"},{"issue":"6","key":"10.1016\/j.euroneuro.2023.05.008_bib0112","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/ijnp\/pyaa018","article-title":"Reviewing the potential of psychedelics for the treatment of PTSD","volume":"23","author":"Krediet","year":"2020","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2023.05.008_bib0137","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.mehy.2019.02.029","article-title":"Psychedelic medicine: the biology underlying the persisting psychedelic effects","volume":"125","author":"Kuypers","year":"2019","journal-title":"Med. Hypotheses"},{"issue":"5","key":"10.1016\/j.euroneuro.2023.05.008_bib0034","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1080\/02791072.2017.1361559","article-title":"Nourishing the spirit: exploratory research on ayahuasca experiences along the continuum of recovery from eating disorders","volume":"49","author":"Lafrance","year":"2017","journal-title":"J. Psychoactive Drugs"},{"key":"10.1016\/j.euroneuro.2023.05.008_bib0035","doi-asserted-by":"crossref","DOI":"10.1177\/00221678211048049","article-title":"Classic psychedelic use and mechanisms of mental health: exploring the mediating roles of spirituality and emotion processing on symptoms of anxiety, depressed mood, and disordered eating in a community sample","author":"Lafrance","year":"2021","journal-title":"J. Humanistic Psychology"},{"issue":"6","key":"10.1016\/j.euroneuro.2023.05.008_bib0135","doi-asserted-by":"crossref","DOI":"10.3390\/nu9060602","article-title":"Are the gut bacteria telling us to eat or not to eat? Reviewing the role of gut microbiota in the etiology, disease progression and treatment of eating disorders","volume":"9","author":"Lam","year":"2017","journal-title":"Nutrients"},{"issue":"9","key":"10.1016\/j.euroneuro.2023.05.008_bib0062","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.1002\/hbm.23234","article-title":"LSD-induced entropic brain activity predicts subsequent personality change","volume":"37","author":"Lebedev","year":"2016","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.euroneuro.2023.05.008_bib0063","doi-asserted-by":"crossref","DOI":"10.1002\/eat.23776","article-title":"The neurobiological reward system and binge eating: a critical systematic review of neuroimaging studies","author":"Leenaerts","year":"2022","journal-title":"Int. J. Eat. Disord."},{"issue":"3","key":"10.1016\/j.euroneuro.2023.05.008_bib0011","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/BF02850170","article-title":"Citalopram versus fluoxetine for the treatment of patients with bulimia nervosa: a single-blind randomized controlled trial","volume":"23","author":"Leombruni","year":"2006","journal-title":"Adv. Ther."},{"key":"10.1016\/j.euroneuro.2023.05.008_bib0058","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.neuroimage.2017.07.020","article-title":"Two dose investigation of the 5-HT-agonist psilocybin on relative and global cerebral blood flow","volume":"159","author":"Lewis","year":"2017","journal-title":"Neuroimage"},{"issue":"3","key":"10.1016\/j.euroneuro.2023.05.008_bib0076","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1177\/0145445510397178","article-title":"Binge eating and weight control: the role of experiential avoidance","volume":"35","author":"Lillis","year":"2011","journal-title":"Behav. Modif."},{"key":"10.1016\/j.euroneuro.2023.05.008_bib0165","article-title":"Serotonin toxicity of serotonergic psychedelics","author":"Malcolm","year":"2021","journal-title":"Psychopharmacology (Berl.)"},{"issue":"1","key":"10.1016\/j.euroneuro.2023.05.008_bib0146","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1080\/10503307.2012.744111","article-title":"Change mechanisms in psychotherapy: multiperspective assessment and relation to outcome","volume":"23","author":"Mander","year":"2013","journal-title":"Psychother Res"},{"issue":"12","key":"10.1016\/j.euroneuro.2023.05.008_bib0060","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1038\/s41386-020-0718-8","article-title":"Me, myself, bye: regional alterations in glutamate and the experience of ego dissolution with psilocybin","volume":"45","author":"Mason","year":"2020","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.euroneuro.2023.05.008_bib0158","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/nyas.13467","article-title":"Disordered eating and obesity: associations between binge-eating disorder, night-eating syndrome, and weight-related comorbidities","volume":"1411","author":"McCuen-Wurst","year":"2018","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"10.1016\/j.euroneuro.2023.05.008_bib0044","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.psc.2018.10.006","article-title":"Body image in the context of eating disorders","volume":"42","author":"McLean","year":"2019","journal-title":"Psychiatr. Clin. North Am."},{"key":"10.1016\/j.euroneuro.2023.05.008_bib0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpr.2020.101905","article-title":"Cognitive flexibility in acute anorexia nervosa and after recovery: a systematic review","volume":"81","author":"Miles","year":"2020","journal-title":"Clin. Psychol. Rev."},{"issue":"7","key":"10.1016\/j.euroneuro.2023.05.008_bib0040","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/qjmed\/91.7.493","article-title":"Treatment of compulsive behaviour in eating disorders with intermittent ketamine infusions","volume":"91","author":"Mills","year":"1998","journal-title":"QJM"},{"issue":"1","key":"10.1016\/j.euroneuro.2023.05.008_bib0110","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/aje\/kwv291","article-title":"Longitudinal associations among posttraumatic stress disorder, disordered eating, and weight gain in military men and women","volume":"184","author":"Mitchell","year":"2016","journal-title":"Am. J. Epidemiol."},{"issue":"3","key":"10.1016\/j.euroneuro.2023.05.008_bib0111","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1080\/10640266.2020.1869369","article-title":"Posttraumatic stress disorder and eating disorders: maintaining mechanisms and treatment targets","volume":"29","author":"Mitchell","year":"2021","journal-title":"Eat Disord."},{"issue":"6","key":"10.1016\/j.euroneuro.2023.05.008_bib0121","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/s41591-021-01336-3","article-title":"MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study","volume":"27","author":"Mitchell","year":"2021","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.euroneuro.2023.05.008_bib0169","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1177\/0269881110378371","article-title":"The safety and efficacy of {+\/-}3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study","volume":"25","author":"Mithoefer","year":"2011","journal-title":"J. Psychopharmacol."},{"issue":"6","key":"10.1016\/j.euroneuro.2023.05.008_bib0122","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/S2215-0366(18)30135-4","article-title":"3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial","volume":"5","author":"Mithoefer","year":"2018","journal-title":"Lancet Psychiatry"},{"issue":"9","key":"10.1016\/j.euroneuro.2023.05.008_bib0155","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1007\/s00213-019-05249-5","article-title":"MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials","volume":"236","author":"Mithoefer","year":"2019","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.euroneuro.2023.05.008_bib0102","first-page":"1","article-title":"Childhood maltreatment and eating disorder pathology: a systematic review and dose-response meta-analysis","author":"Molendijk","year":"2017","journal-title":"Psychol. Med."},{"issue":"11","key":"10.1016\/j.euroneuro.2023.05.008_bib0096","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.4088\/JCP.v67n1110","article-title":"Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder","volume":"67","author":"Moreno","year":"2006","journal-title":"J. Clin. Psychiatry"},{"issue":"4","key":"10.1016\/j.euroneuro.2023.05.008_bib0117","doi-asserted-by":"crossref","first-page":"e1084","DOI":"10.1038\/tp.2017.54","article-title":"Acute effects of LSD on amygdala activity during processing of fearful stimuli in healthy subjects","volume":"7","author":"Mueller","year":"2017","journal-title":"Transl. Psychiatry"},{"issue":"7754","key":"10.1016\/j.euroneuro.2023.05.008_bib0081","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/s41586-019-1075-9","article-title":"Oxytocin-dependent reopening of a social reward learning critical period with MDMA","volume":"569","author":"Nardou","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.euroneuro.2023.05.008_bib0151","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.forsciint.2018.01.006","article-title":"Is LSD toxic?","volume":"284","author":"Nichols","year":"2018","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.euroneuro.2023.05.008_bib0019","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1124\/pr.115.011478","article-title":"Psychedelics","volume":"68","author":"Nichols","year":"2016","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.euroneuro.2023.05.008_bib0061","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3389\/fnhum.2016.00269","article-title":"Ego-dissolution and psychedelics: validation of the ego-dissolution inventory (EDI)","volume":"10","author":"Nour","year":"2016","journal-title":"Front. Hum. Neurosci."},{"key":"10.1016\/j.euroneuro.2023.05.008_bib0070","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.neubiorev.2015.02.012","article-title":"A reward-centred model of anorexia nervosa: a focussed narrative review of the neurological and psychophysiological literature","volume":"52","author":"O'Hara","year":"2015","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.euroneuro.2023.05.008_bib0147","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2022.863552","article-title":"Using a MDMA- and LSD-group therapy model in clinical practice in switzerland and highlighting the treatment of trauma-related disorders","volume":"13","author":"Oehen","year":"2022","journal-title":"Front. Psychiatry"},{"issue":"5","key":"10.1016\/j.euroneuro.2023.05.008_bib0094","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1002\/cpp.2573","article-title":"Metacognitive beliefs across eating disorders and eating behaviours: a systematic review","volume":"28","author":"Palmieri","year":"2021","journal-title":"Clin. Psychol. Psychother"},{"issue":"1\u20132","key":"10.1016\/j.euroneuro.2023.05.008_bib0152","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2011.08.012","article-title":"MDMA and temperature: a review of the thermal effects of 'Ecstasy' in humans","volume":"121","author":"Parrott","year":"2012","journal-title":"Drug Alcohol Depend."},{"issue":"5","key":"10.1016\/j.euroneuro.2023.05.008_bib0153","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1111\/j.1476-5381.2012.01941.x","article-title":"MDMA and 5-HT neurotoxicity: the empirical evidence for its adverse effects in humans - no need for translation","volume":"166","author":"Parrott","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.euroneuro.2023.05.008_bib0148","doi-asserted-by":"crossref","DOI":"10.1177\/02698811211066709","article-title":"Validation of the Psychological Insight Scale: a new scale to assess psychological insight following a psychedelic experience","author":"Peill","year":"2022","journal-title":"J. Psychopharmacol."},{"issue":"1\u20133","key":"10.1016\/j.euroneuro.2023.05.008_bib0166","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.forsciint.2011.04.008","article-title":"Serotonin toxicity involving MDMA (ecstasy) and moclobemide","volume":"215","author":"Pilgrim","year":"2012","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.euroneuro.2023.05.008_bib0051","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/7854_2016_459","article-title":"Phenomenology, structure, and dynamic of psychedelic states","volume":"36","author":"Preller","year":"2018","journal-title":"Curr. Top Behav. Neurosci."},{"issue":"18","key":"10.1016\/j.euroneuro.2023.05.008_bib0120","doi-asserted-by":"crossref","first-page":"5119","DOI":"10.1073\/pnas.1524187113","article-title":"Effects of serotonin 2A\/1A receptor stimulation on social exclusion processing","volume":"113","author":"Preller","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.euroneuro.2023.05.008_bib0029","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.764112","article-title":"Case report: unexpected remission from extreme and enduring bulimia nervosa with repeated ketamine assisted psychotherapy","volume":"12","author":"Ragnhildstveit","year":"2021","journal-title":"Front. Psychiatry"},{"issue":"9","key":"10.1016\/j.euroneuro.2023.05.008_bib0074","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.brat.2010.05.009","article-title":"Rumination, experiential avoidance, and dysfunctional thinking in eating disorders","volume":"48","author":"Rawal","year":"2010","journal-title":"Behav. Res. Ther."},{"issue":"1","key":"10.1016\/j.euroneuro.2023.05.008_bib0133","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s40268-015-0081-0","article-title":"Ketamine as a potential treatment for suicidal ideation: a systematic review of the literature","volume":"15","author":"Reinstatler","year":"2015","journal-title":"Drugs R. D."},{"issue":"2","key":"10.1016\/j.euroneuro.2023.05.008_bib0036","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s40519-018-0619-6","article-title":"An exploratory study of experiences with conventional eating disorder treatment and ceremonial ayahuasca for the healing of eating disorders","volume":"25","author":"Renelli","year":"2018","journal-title":"Eat. Weight Disord."},{"issue":"6","key":"10.1016\/j.euroneuro.2023.05.008_bib0106","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1097\/YCO.0000000000000545","article-title":"Eating disorders and posttraumatic stress disorder","volume":"32","author":"Rijkers","year":"2019","journal-title":"Curr. Opin. Psychiatry"},{"issue":"1","key":"10.1016\/j.euroneuro.2023.05.008_bib0032","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s40337-022-00588-9","article-title":"A case series of group-based ketamine-assisted psychotherapy for patients in residential treatment for eating disorders with comorbid depression and anxiety disorders","volume":"10","author":"Robison","year":"2022","journal-title":"J. Eat Disord."},{"issue":"12","key":"10.1016\/j.euroneuro.2023.05.008_bib0144","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1038\/npp.2013.150","article-title":"Randomized controlled crossover trial of ketamine in obsessive-compulsive disorder: proof-of-concept","volume":"38","author":"Rodriguez","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2023.05.008_bib0023","doi-asserted-by":"crossref","first-page":"974","DOI":"10.3389\/fphar.2017.00974","article-title":"Quality of acute psychedelic experience predicts therapeutic efficacy of psilocybin for treatment-resistant depression","volume":"8","author":"Roseman","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"9","key":"10.1016\/j.euroneuro.2023.05.008_bib0149","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1177\/0269881119855974","article-title":"Emotional breakthrough and psychedelics: validation of the Emotional Breakthrough Inventory","volume":"33","author":"Roseman","year":"2019","journal-title":"J. Psychopharmacol."},{"issue":"12","key":"10.1016\/j.euroneuro.2023.05.008_bib0131","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1177\/0269881116675512","article-title":"Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial","volume":"30","author":"Ross","year":"2016","journal-title":"J. Psychopharmacol."},{"issue":"6","key":"10.1016\/j.euroneuro.2023.05.008_bib0171","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1080\/14740338.2022.2054988","article-title":"Ayahuasca, a potentially rapid acting antidepressant: focus on safety and tolerability","volume":"21","author":"Rossi","year":"2022","journal-title":"Expert. Opin. Drug Saf."},{"issue":"8","key":"10.1016\/j.euroneuro.2023.05.008_bib0084","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.biopsych.2014.11.015","article-title":"Acute Effects of Lysergic Acid Diethylamide in Healthy Subjects","volume":"78","author":"Schmid","year":"2015","journal-title":"Biol. Psychiatry"},{"issue":"Pt 3","key":"10.1016\/j.euroneuro.2023.05.008_bib0073","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1348\/014466505X53902","article-title":"Anorexia nervosa: valued and visible. A cognitive-interpersonal maintenance model and its implications for research and practice","volume":"45","author":"Schmidt","year":"2006","journal-title":"Br. J. Clin. Psychol."},{"issue":"5","key":"10.1016\/j.euroneuro.2023.05.008_bib0033","doi-asserted-by":"crossref","first-page":"e03869","DOI":"10.1002\/ccr3.3869","article-title":"A longitudinal case series of IM ketamine for patients with severe and enduring eating disorders and comorbid treatment-resistant depression","volume":"9","author":"Schwartz","year":"2021","journal-title":"Clin. Case Rep."},{"key":"10.1016\/j.euroneuro.2023.05.008_bib0030","doi-asserted-by":"crossref","first-page":"763","DOI":"10.3389\/fpsyt.2020.00763","article-title":"Remission from chronic anorexia nervosa with ketogenic diet and ketamine: case report","volume":"11","author":"Scolnick","year":"2020","journal-title":"Front. Psychiatry."},{"issue":"4","key":"10.1016\/j.euroneuro.2023.05.008_bib0142","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1177\/0269881121991792","article-title":"First study of safety and tolerability of 3,4-methylenedioxymethamphetamine-assisted psychotherapy in patients with alcohol use disorder","volume":"35","author":"Sessa","year":"2021","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2023.05.008_bib0114","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.neulet.2016.07.004","article-title":"MDMA and PTSD treatment: \"PTSD: From novel pathophysiology to innovative therapeutics\"","volume":"649","author":"Sessa","year":"2017","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.euroneuro.2023.05.008_bib0143","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajp.2020.102183","article-title":"Clinical utility of repeated intravenous ketamine treatment for resistant obsessive-compulsive disorder","volume":"52","author":"Sharma","year":"2020","journal-title":"Asian J Psychiatr"},{"issue":"17","key":"10.1016\/j.euroneuro.2023.05.008_bib0059","doi-asserted-by":"crossref","first-page":"4982","DOI":"10.1002\/hbm.25174","article-title":"P300-mediated modulations in self-other processing under psychedelic psilocybin are related to connectedness and changed meaning: a window into the self-other overlap","volume":"41","author":"Smigielski","year":"2020","journal-title":"Hum. Brain Mapp."},{"issue":"4","key":"10.1016\/j.euroneuro.2023.05.008_bib0020","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/jcph.1995","article-title":"MDMA-assisted psychotherapy for treatment of posttraumatic stress disorder: a systematic review with meta-analysis","volume":"62","author":"Smith","year":"2022","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.euroneuro.2023.05.008_bib0043","doi-asserted-by":"crossref","unstructured":"Smolak L., Levine M.P. Body image, disordered eating, and eating disorders: connections and disconnects. In: Smolak L, Levine MP, eds. The Wiley Handbook of Eating Disorders, Assessment, Prevention, Treatment, Policy, and Future Directions. Vol 1. West Sussex: John Wiley & Sons, Ltd.; 2015:2\u201310.","DOI":"10.1002\/9781118574089.ch1"},{"key":"10.1016\/j.euroneuro.2023.05.008_bib0100","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1590\/1516-4446-2020-1099","article-title":"Risk factors for eating disorders: an umbrella review of published meta-analyses","author":"Solmi","year":"2021","journal-title":"Braz J. Psychiatry"},{"issue":"4","key":"10.1016\/j.euroneuro.2023.05.008_bib0037","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1007\/s40519-020-01000-8","article-title":"Positive effects of psychedelics on depression and wellbeing scores in individuals reporting an eating disorder","volume":"26","author":"Spriggs","year":"2021","journal-title":"Eat. Weight Disord."},{"key":"10.1016\/j.euroneuro.2023.05.008_bib0042","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.735523","article-title":"Study protocol for \"psilocybin as a treatment for anorexia nervosa: a pilot study\"","volume":"12","author":"Spriggs","year":"2021","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.euroneuro.2023.05.008_bib0161","article-title":"Body mass index (BMI) does not predict responses to psilocybin","author":"Spriggs","year":"2022","journal-title":"J. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.euroneuro.2023.05.008_bib0015","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s40337-021-00424-6","article-title":"The maudsley anorexia nervosa treatment for adults (MANTRA): a feasibility case series of an integrated group based approach","volume":"9","author":"Startup","year":"2021","journal-title":"J. Eat Disord."},{"issue":"5","key":"10.1016\/j.euroneuro.2023.05.008_bib0160","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1177\/0269881121998322","article-title":"Prediction of MDMA response in healthy humans: a pooled analysis of placebo-controlled studies","volume":"35","author":"Studerus","year":"2021","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2023.05.008_bib0134","doi-asserted-by":"crossref","DOI":"10.1007\/s40261-022-01193-z","article-title":"Efficacy and safety of subcutaneous esketamine in the treatment of suicidality in major depressive disorder and bipolar depression","author":"Surjan","year":"2022","journal-title":"Clin. Drug Investig."},{"key":"10.1016\/j.euroneuro.2023.05.008_bib0103","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/erv.972","article-title":"Traumatic events, posttraumatic stress symptomatology and somatoform symptoms in eating disorder patients","volume":"18","author":"Tagay","year":"2010","journal-title":"Eur. Eat Disorders Rev."},{"issue":"5","key":"10.1016\/j.euroneuro.2023.05.008_bib0154","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1080\/02791072.2017.1320734","article-title":"Psilocybin-assisted therapy: a review of a novel treatment for psychiatric disorders","volume":"49","author":"Thomas","year":"2017","journal-title":"J. Psychoactive Drugs"},{"issue":"1","key":"10.1016\/j.euroneuro.2023.05.008_bib0072","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-244X-13-110","article-title":"Anorexia nervosa is linked to reduced brain structure in reward and somatosensory regions: a meta-analysis of VBM studies","volume":"13","author":"Titova","year":"2013","journal-title":"BMC Psychiatry"},{"issue":"5","key":"10.1016\/j.euroneuro.2023.05.008_bib0002","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.biopsych.2018.03.014","article-title":"Prevalence and correlates of DSM-5-defined eating disorders in a nationally representative sample of U.S. adults","volume":"84","author":"Udo","year":"2018","journal-title":"Biol. Psychiatry"},{"issue":"4","key":"10.1016\/j.euroneuro.2023.05.008_bib0014","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/erv.2683","article-title":"Meta-analysis on the efficacy of psychological treatments for anorexia nervosa","volume":"27","author":"van den Berg","year":"2019","journal-title":"Eur. Eat. Disord. Rev."},{"issue":"8","key":"10.1016\/j.euroneuro.2023.05.008_bib0031","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.amp.2021.08.004","article-title":"Psilocybin in the treatment of anorexia nervosa: the English transition of a French 1959 case study","volume":"179","author":"Verroust","year":"2021","journal-title":"Annales M\u00e9dico-psychologiques, revue psychiatrique"},{"issue":"4","key":"10.1016\/j.euroneuro.2023.05.008_bib0069","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/eat.20699","article-title":"Altered striatal response to reward in bulimia nervosa after recovery","volume":"43","author":"Wagner","year":"2010","journal-title":"Int. J. Eat. Disord."},{"issue":"5","key":"10.1016\/j.euroneuro.2023.05.008_bib0087","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1177\/0022167817709585","article-title":"Patients\u2019 accounts of increased \u201cconnectedness\u201d and \u201cacceptance\u201d after psilocybin for treatment-resistant depression","volume":"57","author":"Watts","year":"2017","journal-title":"J. Humanistic Psychol."},{"key":"10.1016\/j.euroneuro.2023.05.008_bib0088","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3389\/fpsyt.2020.00005","article-title":"Learning to let go: a cognitive-behavioral model of how psychedelic therapy promotes acceptance","volume":"11","author":"Wolff","year":"2020","journal-title":"Front. Psychiatry"},{"issue":"3","key":"10.1016\/j.euroneuro.2023.05.008_bib0089","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1177\/02698811211073758","article-title":"The acceptance\/avoidance-promoting experiences questionnaire (APEQ): a theory-based approach to psychedelic drugs' effects on psychological flexibility","volume":"36","author":"Wolff","year":"2022","journal-title":"J. Psychopharmacol."},{"issue":"7","key":"10.1016\/j.euroneuro.2023.05.008_bib0092","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/jclp.21945","article-title":"Psychological change mechanisms in anorexia nervosa treatments: how much do we know?","volume":"69","author":"Wollburg","year":"2013","journal-title":"J. Clin. Psychol."},{"key":"10.1016\/j.euroneuro.2023.05.008_bib0022","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyg.2022.873279","article-title":"Psychedelics and psychotherapy: cognitive-behavioral approaches as default","volume":"13","author":"Yaden","year":"2022","journal-title":"Front. Psychol."},{"key":"10.1016\/j.euroneuro.2023.05.008_bib0086","doi-asserted-by":"crossref","first-page":"782","DOI":"10.3389\/fpsyt.2020.00782","article-title":"Post-psychedelic reductions in experiential avoidance are associated with decreases in depression severity and suicidal ideation","volume":"11","author":"Zeifman","year":"2020","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.euroneuro.2023.05.008_bib0157","unstructured":"Zhou K., et\u00a0al. Predictors of hallucinogen persisting perception disorder symptoms, delusional ideation and magical thinking following naturalistic psychedelic Use. PREPRINT."},{"issue":"12","key":"10.1016\/j.euroneuro.2023.05.008_bib0005","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/S2215-0366(15)00356-9","article-title":"Anorexia nervosa: aetiology, assessment, and treatment","volume":"2","author":"Zipfel","year":"2015","journal-title":"Lancet Psychiatry"}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X23001098?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X23001098?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T18:06:13Z","timestamp":1760378773000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X23001098"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":171,"alternative-id":["S0924977X23001098"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2023.05.008","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Psychedelics in the treatment of eating disorders: Rationale and potential mechanisms","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2023.05.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}